Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Merck
McKinsey
Cipla
Deloitte
Novartis
Teva
Medtronic
Harvard Business School

Generated: January 19, 2018

DrugPatentWatch Database Preview

D.H.E. 45 Drug Profile

« Back to Dashboard

When do D.h.e. 45 patents expire, and when can generic versions of D.h.e. 45 launch?

D.h.e. 45 is a drug marketed by Valeant and is included in one NDA.

The generic ingredient in D.H.E. 45 is dihydroergotamine mesylate. There are five drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the dihydroergotamine mesylate profile page.
Drug patent expirations by year for D.H.E. 45
Pharmacology for D.H.E. 45
Ingredient-typeErgotamines
Drug ClassErgotamine Derivative
Medical Subject Heading (MeSH) Categories for D.H.E. 45

US Patents and Regulatory Information for D.H.E. 45

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant D.H.E. 45 dihydroergotamine mesylate INJECTABLE;INJECTION 005929-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Moodys
Federal Trade Commission
Novartis
UBS
AstraZeneca
Johnson and Johnson
Express Scripts
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot